BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.6//EN
X-ORIGINAL-URL:https://pbhfa.org/
X-WR-CALNAME:Palm Beach Hedge Fund Association
X-WR-CALDESC:Uniting South Florida's Financial Professionals
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-90968598e1b1d4ae4838f0ad8e39bf11@pbhfa.org
DTSTART:20210204T190000Z
DTEND:20210204T203000Z
DTSTAMP:20201028T004600Z
CREATED:20201027
LAST-MODIFIED:20210129
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:The Golden Era Of Medicine: Join Mira Life Science Ventures CEO
DESCRIPTION: \n \n The Palm Beach Hedge Fund Association, a Florida trade association for financial professionals and ultra high net worth investors and IPO Edge, will host a fireside chat Thursday, February 4 at 2pm EST with Mira Life Science Ventures – A Golden Era of Medicine, Investing in Early Stage Life Science Companies. The event will last approximately one hour with time set aside for public audience Q&A.\nCLICK HERE TO REGISTER\nThe virtual event will feature Mira Life Science Ventures CEO Dr. Kurt Gehlsen, who will discuss how the company analyzes early, game-changing medical companies. The company isn’t currently traded publicly but qualified investors can take part by contacting the company here.  Mira Life Science Ventures is looking to raise up to $250 million.\nThe COVID-19 pandemic has highlighted the strengths, weaknesses and opportunities in healthcare systems and in the pharmaceutical industry. With the technological advancements in the last 10 years, including those in computing power and artificial intelligence, a new generation of treatments will address the most pressing unmet medical needs.\nMira Life Science Ventures was established to capitalize on these breakthrough advancements and facilitate their accelerated development leading to improved patient access and helping to advance our healthcare system. Investing in life sciences can be incredibly rewarding, both financially and ethically, yet it needs deep experience and expertise.\nMIRA Life Science has identified a number of potentially groundbreaking innovations at various stages of development that it could immediately deploy capital towards. It has 12-15 in the pipeline including products to target the tumor-stromal support system, infectious disease diagnostic technology, a new viral vector platform used for applications in oncology to autoimmune disease, technology to eliminate life threatening side effects of kidney dialysis, next generation urinary catheter technology, a novel drug discovery platform and a B-cell autoimmune platform.\nDr. Gehlsen will discuss:\n\nHow Mira Life Science Ventures’ management team has decades of experience in the worlds of science and business\nWhy family offices, hedge funds and individuals are not set-up for the detailed and rigorous diligence required to choose the best companies and technologies in the life sciences\nHow Investors interested in having a small portion of their investment portfolio in early-stage, disruptive life science technologies can leverage the Mira Team for all due diligence and selection of investments\nWhat has changed in the treatment of cancer in recent years\nWhat are the challenges when investing in healthcare\nHow the corporate structure of Mira allows for maximum flexibility for investments and at the same time is focused on generating significant, long-term, returns\n\nAbout Dr. Gehlsen:\n\nSeasoned entrepreneur in the life sciences business for over 30 years\nFormer scientist who became a CEO, worked at large Pharma, in both start-up and public companies\nHas two approved products, a hundred patents/patent applications and more than 100 publications\nBaccalaureate degrees in Civil Engineering and Biology from the University of Arizona, and Doctorate degrees from the University of Arizona College of Medicine\n\n
URL:https://pbhfa.org/events/deal-making-social-with-the-mandarin-oriental-in-boca-raton/
ATTACH;FMTTYPE=image/jpeg:https://pbhfa.org/wp-content/uploads/2020/10/kurt-gehlson.jpg
END:VEVENT
END:VCALENDAR